Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuliya Yasinskaya

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Anti-Infective Therapy|August 4, 2011
Models and approaches for anti-TB drug testingYuliya Yasinskaya, Leonard Sacks
Therapeutic Drug Monitoring|September 26, 2003
Carbapenems in pediatricsKassa Ayalew, Sumati Nambiar, Yuliya Yasinskaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2021
A Regulatory Review Approach for Evaluation of Micafungin for Treatment of Neonatal CandidiasisGillian Taormina, Ramya Gopinath, Jason Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2022
Reply to White et alEliford Kitabi, Timothy J Bensman, Justin C Earp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2021
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe MalariaEliford Kitabi, Timothy J Bensman, Justin C Earp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2021
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal DrugsElizabeth O'Shaughnessy, Yuliya Yasinskaya, Cheryl Dixon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2023
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical NeedYuliya Yasinskaya, Shukal Bala, Ursula Waack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 2024
FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of GonorrheaHiwot Hiruy, Shukal Bala, James M Byrne, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Anti-Infective Therapy|August 4, 2011
Models and approaches for anti-TB drug testingYuliya Yasinskaya, Leonard Sacks
Therapeutic Drug Monitoring|September 26, 2003
Carbapenems in pediatricsKassa Ayalew, Sumati Nambiar, Yuliya Yasinskaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2021
A Regulatory Review Approach for Evaluation of Micafungin for Treatment of Neonatal CandidiasisGillian Taormina, Ramya Gopinath, Jason Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2022
Reply to White et alEliford Kitabi, Timothy J Bensman, Justin C Earp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2021
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe MalariaEliford Kitabi, Timothy J Bensman, Justin C Earp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2021
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal DrugsElizabeth O'Shaughnessy, Yuliya Yasinskaya, Cheryl Dixon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2023
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical NeedYuliya Yasinskaya, Shukal Bala, Ursula Waack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 2024
FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of GonorrheaHiwot Hiruy, Shukal Bala, James M Byrne, et al.
Pageof 1